The thyroid gland, necessary for normal human growth and development, functions as an essential regulator of metabolism by the production and secretion of appropriate levels of thyroid hormone. However, assessment of abnormal thyroid function may be challenging suggesting a more fundamental understanding of normal function is needed. One way to characterize normal gland function is to study the epigenome and resulting transcriptome within its constituent cells. This study generates the first published reference epigenomes for human thyroid from four individuals using ChIP-seq and RNA-seq. We profiled six histone modifications (H3K4me1, H3K4me3, H3K27ac, H3K36me3, H3K9me3, H3K27me3), identified chromatin states using a hidden Markov model, produced a novel quantitative metric for model selection and established epigenomic maps of 19 chromatin states. We found that epigenetic features characterizing promoters and transcription elongation tend to be more consistent than regions characterizing enhancers or Polycomb-repressed regions and that epigenetically active genes consistent across all epigenomes tend to have higher expression than those not marked as epigenetically active in all epigenomes. We also identified a set of 18 genes epigenetically active and consistently expressed in the thyroid that are likely highly relevant to thyroid function. Altogether, these epigenomes represent a powerful resource to develop a deeper understanding of the underlying molecular biology of thyroid function and provide contextual information of thyroid and human epigenomic data for comparison and integration into future studies.
Introduction
The normal human thyroid is a homogeneous tissue mainly composed of two cell types: follicular cells and parafollicular cells. Thyroid follicular cells are epithelial cells responsible for the production, storage and secretion of thyroid hormone. Parafollicular cells (also known as C cells) account for only a relatively small proportion of the thyroid cells (Eladio & Gershon 1978) and produce calcitonin.
The thyroid gland produces and secretes hormones necessary for growth and development and is involved with the regulation of metabolism. Assessment of thyroid function is based on blood serum concentrations of thyroid-related hormones (thyroid-stimulating hormone (TSH), triiodothyronine (T3) or thyroxine (T4)) in predefined normal ranges (Führer et al. 2015) . However, the definition of a 'normal' TSH, T3 and T4 concentration range is controversial (Führer et al. 2015) when variability in individual factors such as sex, body mass index, exclusion of incident thyroid disease, ethnicity and iodine and selenium intake are considered. Furthermore, thyroid nodules are common, diagnosed in 5% of the general population by palpation and in 50% by ultrasound (Gharib & Papini 2007) suggesting frequent local heterogeneity within thyroid glands. The result is that accurate assessment of abnormal thyroid states across individuals is challenging.
One way to study thyroid function is to examine the epigenetics involved in the regulation of thyroid gene expression and transcription. Epigenetics, referring to the reversible changes in chromatin and DNA that can regulate gene activity and expression, include the posttranslational modifications of histone proteins and DNA methylation. In cells, DNA is packaged into chromatin, a complex of DNA, proteins and RNA. The basic repeating unit of chromatin, a nucleosome, consists of about 200 base pairs (bp) of DNA wrapped around both a histone protein octamer and a linker protein. This histone octamer can be chemically modified to signal an activation or repression of transcription; such modifications include H3K4me3 associated with active promoters, H3K27ac with active enhancers and promoters, H3K4me1 with active enhancers, H3K36me3 with transcribed gene bodies, H3K9me3 with heterochromatin and H3K27me3 with Polycomb-repressed regions (Roadmap Epigenomics Consortium 2015) . Undoubtedly, the distribution of different histone modifications reveals different epigenetic signals. Tools such as ChromHMM (Ernst & Kellis 2012) and Segway (Hoffman et al. 2012) have been developed to represent combinations of epigenetic features by partitioning the epigenome into various defined chromatin states.
Genomewide epigenomic maps of functional elements encompassing promoters, enhancers, silencers and transcription factor-binding sites, across an increasing number of different cell types and tissues, have been generated (Roadmap Epigenomics Consortium 2015) . This and other large-scale international projects have aimed to sequence and decipher the human epigenomes of various cell types in order to understand how epigenetic processes contribute to human biology and disease (Stunnenberg et al. 2016) .
The goals of this work are to provide a resource of human thyroid epigenomic data and to introduce a novel quantitative metric for model selection. In this study, reference epigenomes were generated from the thyroid tissues of four individuals. Each specimen has a complete set of six histone marks (H3K4me1, H3K4me3, H3K27ac, H3K36me3, H3K9me3, H3K27me3) profiled with ChIP-seq, a methylome, a transcriptome and a normal and disease-matched genomic sequence. We partitioned the epigenomes into various chromatin states and developed a novel quantitative metric for model selection. We selected a model for further analysis and compared chromatin state consistencies across four epigenomes. We found that the epigenetic features characterizing promoters and transcription elongation tend to be more consistent across samples. We also found that genes that are consistently epigenetically active across all individuals tend to have higher expression than genes not marked as epigenetically active or only active in a subset of epigenomes. The findings provide four reference thyroid epigenomes as a valuable resource for future study of the function and regulation of the human thyroid gland.
Materials and methods

Samples
Four human adult thyroid specimens were provided from surgical resections conducted at St. Paul's Hospital, Vancouver, British Columbia. The pathologic findings in the glands included two follicular adenomas, one goiter and one papillary carcinoma (Supplementary Table 1 , see section on supplementary data given at the end of this article). The pathologic findings reflect the challenge of obtaining normal thyroid tissue from healthy individuals.
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The specimens referred to as 'normal' in this study are from microscopically uninvolved thyroid tissue in the resected thyroid glands.
ChIP sequencing and RNA sequencing
Human thyroid chromatin immunoprecipitation sequencing (ChIP-seq) and RNA sequencing (RNA-seq) data were collected as previously described (Pellacani et al. 2016) . The antibodies for ChIP-seq were obtained from Diagenode (Denville, NJ, USA), Abcam and Cell Signaling Technologies. The catalog numbers for each company, respectively, are C15410037/pAb-037-050 (H3K4me1), C15410056/pAb-056-050 (H3K9me3), C15410195/pAb-195-050 (H3K27me3); ab4729 (H3K27ac), ab9050 (H3K36me3) and 9751S (H3K4me3). For sample CEMT_86/87, one lane of sequencing was merged with native ChIP protocol. With regards to RNA-seq, purification of RNA was followed by poly-A RNA selection. Conversion of RNA to cDNA was done by random priming. 75 base pair paired-end reads were sequenced on an Illumina HiSeq 2500 (Illumina Inc., San Diego, CA, USA). Alignment was to the GRCh37-lite reference and processed datasets and all underlying raw DNA sequences have been deposited at the European Genome-phenome Archive (EGA, www.ebi. ac.uk/ega/) under accession number EGAS00001000552. In this work, CEMT_40-45 and CEMT_86-87 were the normal and diseased thyroid samples utilized for analysis. Detailed methodology for ChIP-seq and RNA-seq library construction, read alignment and data processing is available in the Supplemental Experimental Procedures of Pellacani et al. (2016) at www.epigenomes.ca/protocolsand-standards or upon request.
Promoters
In this study, promoters were defined to be regions around the annotated transcription start site (TSS) +/− 1 (kilobase pair) kbp. 1 kbp from the TSS was used given that this distance encapsulates the promoter signal as observed in the RefSeq TSS neighborhood enrichments generated by ChromHMM (Fig. 3C) . The coordinates for the TSS promoter regions were obtained from the Ensembl GRCh37 Release 75 Gene sets GTF file that is available at http://feb2014.archive.ensembl.org/info/data/ftp/ index.html. The gene set was filtered for 'protein_coding' (source) 'transcript' (feature) on chromosomes 1-22, X and Y. In total, we obtain 81,732 transcripts derived from 20,314 protein-coding genes across the standard chromosomes. Altogether, the 20,314 genes encompass 43% of the genome, with their exons and coding sequences representing 2.5% and 1.2% of the genome, respectively.
Estimating transcript abundance, gene expression and gene variance
Detailed methodology for estimating transcript abundance, gene expression and gene variance is in the Supplementary Materials and methods. In brief, we used Salmon, v0.7.2 (Patro et al. 2017) to estimate transcript abundance from 75nt in length RNA-seq reads. The reference transcriptome was downloaded from the UCSC Table Browser . The function 'salmon index' was used to index the reference transcriptome, while 'salmon quant' was used to estimate transcript abundance measured in transcripts per million (TPM). To sum up the Salmon estimated transcript abundances (and read counts) within genes for gene-level abundances, the tximport::tximport R function, v1.2.0 (Soneson et al. 2015) was used. The regularized logarithm transformation (rlog) function of the DESeq2 R package, v1.14.0 (Love et al. 2014) was then used to transform tximport generated read count data to render them homoskedastic. Gene variance was calculated on the rlog transformed read counts.
Motifs
We used HOMER v4.8 (Heinz et al. 2010 ) to find enriched motifs in genomic regions using 'findMotifsGenome.pl' with options as follows: '-size given'.
Results
Reference epigenomes of thyroid tissue
Reference epigenomes have been used to describe regions of functional interest such as promoter or transcription factor-binding sites (Roadmap Epigenomics Consortium 2015) . Reference epigenomes also have been used to provide context to genomic locations such as single nucleotide variants (SNVs) or expression quantitative trait loci (eQTLs) (González-Peñas et al. 2016) . In this study, reference epigenomes from tumor and adjacent normal thyroid tissue of four human adult subjects. In total, we generated 56 histone modification ChIP-seq data sets covering six histone modifications and an input DNA control, 8 DNA methylation data sets and 8 RNA-seq data sets. H3K4me1, H3K4me3, H3K27ac, H3K36me3,
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H3K9me3 and H3K27me3 are the six histone modifications of this study, and they coincide with the core set of histone modifications profiled as part of the International Human Epigenome Consortium (Stunnenberg et al. 2016) . These data can be viewed on the UCSC Genome and Wash U Epigenome Browsers through www.epigenomes.ca/datarelease/ and through a link provided in www.bcgsc.ca/ data/thyroid (Fig. 1) .
Defining chromatin states
ChromHMM (Ernst & Kellis 2012) , an implementation of a hidden Markov model (HMM), uses epigenetic features such as histone modifications to represent observed states and unobserved, or hidden, states to represent chromatin states. Generally, HMMs have 2 parameters: (1) emission probabilities representing the observed (e.g. histone) probability of a hidden state and (2) 
Chromatin states correlate with genomic features
The chromatin states correlated with various known genomic features (Fig. 3) . States 1-4 are enriched in regions of transcription initiation and promoters (Fig. 3C ). H3K36me3-associated emissions correlate with genes, introns and exons in states 5-9, suggesting these states are related to transcribed gene bodies. In comparison, states 9-12 have emissions associated with H3K4me1, Figure 2 Plots showing the homogeneity cost used for model selection. Formulation for the homogeneity cost is presented in the Supplementary Methods. Scores were computed for 26 ChromHMM generated candidate models. The number of hidden states ranged from k = 11-23 states. Input was treated as a control (left) and as a mark (right). 19 states with input as a control and 20 states with input as a mark produced the lowest models with the homogeneity cost. 19 states with input as control were chosen for the model to use for further analysis. 
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which is generally considered to be associated with gene enhancers (Roadmap Epigenomics Consortium 2015), but may also be associated with other functionality (Cui et al. 2009 , Cheng et al. 2014 . In state 16, the H3K4me1 and H3K27me3 emissions are indicative of a bivalent enhancer state. According to the overlap enrichment of genomic features (Fig. 3B) , there is a lack of gene enrichment in states 14-15 and 17-19. In state 17, there is emission for all histone marks, suggesting this state may be associated with repetitive regions such as in (Ernst et al. 2011) . In contrast, state 19 is likely an epigenetically unmarked state based upon the rationale that state 19 has no emission in any of the histone marks, while covering the greatest percentage of the genome. Based on a combination of histone mark emissions probabilities (Fig. 3A) , enrichment in genomic features ( Fig. 3B and C) and comparison with published chromatin states (Roadmap Epigenomics Consortium 2015), we have labeled the states with biologically meaningful labels (Fig. 3A) . Furthermore, when the levels of DNA methylation were measured, we found that the active TSS state (state 1) had, as expected, the lowest level of methylation across chromatin states, which was consistent across all samples measured ( Supplementary  Fig. 1 ). The chromatin state segmentations can be viewed on the UCSC Genome Browser through a link provided in www.bcgsc.ca/data/thyroid (Fig. 1) .
Stability of chromatin states
We do not know how much epigenetic variation exists in the population and thus sought to annotate stable and unstable states. In this study, we were interested in characterizing regions that were epigenetically consistent. We found that promoter (state 1), transcribed (states 5 and 7), and quiescent (state 19) states were consistently marked across the normal thyroid epigenomes of four individuals ( Fig. 4A and B) . Strikingly other chromatin states were highly specific for an individual (Fig. 4) . Furthermore, we found the epigenetic consistency is reduced in the other states, and the states lacking the most agreement across specimens are regions flanking downstream of TSS (states 4) and repeats associated with artifacts (state 17) (Fig. 4C ).
Epigenetically marked promoters and relation with gene expression
The promoter state labeled as active TSS (state 1) was found to be the most epigenetically consistent state Overview of epigenetic consistency across 4 thyroid epigenomes. The genome was divided into 15,181,508 bins. Each bin is 200 bp in length and is marked by a chromatin state. For a particular bin across different individuals, the chromatin state may be the same or it may be different. If a bin was partitioned as state 1 consistently across four epigenomes, then the bin count for state 1 at x = 4 is incremented. If the states for a bin across four epigenomes were {1, 1, 2, 1}, then the bin counts for state 1 at x = 3 and state 2 at x = 1 is incremented. We define a bin as epigenetically consistent when the chromatin state is the same across all individuals. (Fig. 4C) . 101,278 out of 15,181,508 genomic bins were partitioned to this state in at least one epigenome and 36.5% of the 101,278 bins were found to be epigenetically consistent across all four epigenomes. For any given epigenome, a bin partitioned as state 1 had an average probability of 57, 19, 13 and 11% of also being partitioned as state 1 in three, two, one and zero other epigenomes, respectively (Fig. 4C) . We next associated bins partitioned as state 1 to genes if the bin is within a gene's promoter (defined as TSS +/− 1kbp). A majority of state 1 bins (77.4%) were found within protein-coding gene promoters (Fig. 5A) . This value increased to 91.2% when we consider only bins consistently partitioned as state 1 across all four epigenomes. 13,175 out of 20,154 known protein coding genes were associated with bins partitioned as state 1 in at least one epigenome and 10,460 known protein coding genes to bins partitioned as state 1 across all four epigenomes (Fig. 5B) .
We next grouped the genes by the epigenetic consistency of state 1 in gene promoters and compared their levels of gene expression. A gene is epigenetically active if the promoter region is characterized by state 1 in at least one epigenome. We hypothesized that genes that are epigenetically active across all four epigenomes will have higher expression than genes that are not epigenetically active in any epigenome. When we grouped expression by the number of epigenetically active promoters shared across epigenomes, we found that indeed the expression tends to be higher in genes partitioned as epigenetically active in more epigenomes ( Fig. 5C and D ; this behavior is also the case in the other samples). Specifically, expression is on average 9.7-fold higher in genes characterized as epigenetically active than genes not characterized as epigenetically active in any epigenome. Furthermore, expression is on average 4.4-fold higher in genes that are epigenetically active across all four epigenomes than genes that are epigenetically active in only one epigenome. Similarly, when we grouped genes into different brackets of expression, we found that genes with high expression tend to be epigenetically active in all epigenomes (Fig. 5E) . We also find that 90.9% of genes with expression between 100 and 1000 TPM is epigenetically active in all epigenomes and this proportion drops to 44.3% for genes with expression between 1 and 10 TPM and 7.9% for genes with expression between 0.1 and 1 TPM (Fig. 5E ).
Enhancers
Chromatin states characterized as enhancers (states 8-11) were less consistent than states characterized as promoters (Fig. 4) . Nevertheless, we find regions epigenetically consistent across all thyroid specimens for genic (state 8 and 9), active (state 10) and weak (state 11) enhancer type chromatin states. Sequence analysis of the genomic DNA in regions shared by the four samples (2527 regions for state 8; 4663 for state 9; 22,604 for state 10; and 9463 for state 11) indicate that 
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the NF1 response element (CYTGGCABNSTGCCAR) was the most overrepresented sequence motif in enhancer states 8, 10 and 11. Other transcription factor response elements common across enhancer states 8, 10 and 11 are TLX (CTGGCAGSCTGCCA), PAX8
(GTCATGCHTGRCTGS) and PAX5 (GCAGCCAAGCRTGACH). In the literature, PAX8 has been found to be involved with thyroid organogenesis and the maintenance of the thyroid-differentiated state (Trueba et al. 2005) . PAX8 may also have diagnostic utility in thyroid epithelial neoplasms given its high expression in papillary carcinomas, follicular adenomas, follicular carcinomas and 79% of anaplastic carcinomas (Nonaka et al. 2008) . The top 3 motifs of each enhancer chromatin state are shown in (Table 1) .
Thyroid transcript abundance
With regards to estimating transcript abundances, we found that the most highly expressed transcripts, representing 95% of the protein coding RNA-seq reads, are made up of on average 7194 top genes and the top 10,000 genes account for an average of 98% of detected transcript reads (Fig. 6) . Across the four specimens, the top 25 most highly expressed genes (accounting for an average of 19% of transcripts) collectively consists of 42 unique protein coding genes and 10 of these genes are consistent across the four specimens (Table 2) . Furthermore, motif analysis of active enhancers around these genes is described in the Supplementary Materials.
Epigenetically active and consistently expressed genes in the thyroid
To further characterize the thyroid, we identified a set of genes that were likely highly relevant for thyroid function. These genes are ideally epigenetically active and consistently expressed, as epigenetically active genes are presumed poised for transcription and consistently expressed genes with low expression variance across specimens are considered to be under stringent transcriptional control. We consider a gene as epigenetically active if a bin within the gene promoter is partitioned as state 1. Previously, we found 13,175 genes to be epigenetically active in at least one epigenome and 10,460 genes to be epigenetically active across all four epigenomes (Fig. 5B) . We considered a gene as consistently expressed if (1) it was within the intersection of the top 2000 most highly expressed gene in each specimen and (2) it is in the set of 2000 genes with the lowest variance across the normal specimens. Overall, the 2000 most highly expressed genes have a minimum expression of 29 TPM and accounted for an average of 76% of the proteincoding RNA-seq transcripts. Within the top 2000 genes from each of the four specimens, there was a total of 3024 genes and the intersection defined 1183 genes across the four specimens. Intersecting the set of 10,460 genes that are epigenetically active across all four epigenomes, 1183 genes that have high expression, and 2000 genes with low variance, we arrived at a set of 137 genes (Fig. 7A ). Examining this set of genes using Metascape (Tripathi et al. 2015) , we find predominantly general processes such as metabolic processes, protein folding, transport and secretion (Fig. 7B) . The top 3 Gene Ontology (GO) States 8 & 9 = genic enhancers, 10 = active enhancer, and 11 weak enhancers. TF stands for transcription factor. Motif enrichment was performed using HOMER software, state 9 has enrichment in only 1 motif, and Benjamini corrected P-values < 0.03. The list of all motifs (and corrected P-values) are available in the supplements.
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terms are RNA localization (GO:0006403), protein folding (GO:0006457) and negative regulation of cell death (GO:0060548). To prioritize the list of 137 genes, we used the Genome-Tissue Expression (GTEx) project to filter out genes expressed (FPKM >= 10) in 52 non-thyroid tissues ( Supplementary Fig. 2) . This left 18 genes that we consider epigenetically active and consistently expressed in the thyroid that are likely highly relevant to thyroid function (Table 3) .
Discussion
This study has generated the first high quality, published and deeply sequenced reference epigenomes for human thyroid tissue. Number of genes Proportion of transcripts
Figure 6
Average proportion of transcripts in the top 10,000 most abundant protein coding genes. Genes were ranked according to transcript abundances. The gene at rank 1 is the most abundant gene in a given specimen. The average transcript proportion by gene rank were computed across 4 thyroid specimens and is shown by the curved line. The gray ribbon is the mean proportion of transcripts +/− 2 standard deviations. The mean and standard deviation (s.d.) are summary statistics of the proportion of transcripts across the four specimens. In total, there are 42 unique genes. Genes with an asterisk (*) represent genes not epigenetically active (i.e. labeled as active TSS state 1 in the same bin) across 4 specimens (n = 6), while those without an asterisk represent genes that are epigenetically active across 4 specimens (n = 36).
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individuals. We found that some states, such as active TSS (state 1) and transcription (state 5), were more epigenetically consistent and stable than others. Similar to the high consistencies of our active TSS and transcription states (Lee & Park 2016) , predicted chromatin states from nucleotide frequency profiles of K562 or GM12878 cell lines and found that their active promoter and transcribed chromatin states highly coincided with the active promoter and transcribed chromatin state annotations of other cell lines. Furthermore, the quiescent state (state 19) remained largely unchanged across epigenomes, while every other state tended to be variable between epigenomes. Although the epigenetic state, consistent with active promoters showed high levels of consistency between samples, this was not observed for the majority of the remaining states. We also examined whether the differential modification of repressive histone marks (H3K9me3 and H327me3) between samples was also correlated with differential DNA methylation at these sites. As indicated by Supplementary  Fig. 3 , we observed that differential histone modification at these sites did not obviously correlate with differential DNA methylation. This lack of consistency in what should be identical tissues has not been previously characterized. It is not clear whether this is a unique feature of the thyroid or terminally differentiated tissues. It is possible that the states are much more consistent in developing and pluripotent cells where gene regulation may need to be under more stringent control. Using HMMs to partition the epigenome into chromatin states is reliant on the number of hidden states available for partitioning, and different number of hidden states produces different models. There are various methods for model selection. Two popular model selection methods are the Bayesian information criterion (BIC) and the Akaike information criterion (AIC), but a weakness of these selection methods is that they tend to favor higher number of states that are biologically more difficult to distinctly interpret and does not capture sufficiently distinct interactions. Another metric for selecting the number of states produced by ChromHMM is the Factorized Information Criterion (FIC) proposed by Hamada et al. (2015) . However, FIC-HMM indicated more estimated chromatin states than what was selected for by the original ChromHMM analysis done by Ernst et al. (2011) and thus are again biologically more difficult to distinctly interpret. In comparison, the number of states chosen in Roadmap Epigenomics Consortium (2015) was based upon the manual consideration on evaluation for the number of states, which capture all key interactions between chromatin marks. As a result, Roadmap used 15 states for 5 marks and 18 states for 6 marks. Similarly, the 25 states presented in Hoffman et al. (2013) was selected by a manual compromise between capturing all of the potential complexity of chromatin mark combinations (which requires very large numbers of states) and generating models that are easily interpretable and maximally useful for interpreting genomic features, which requires maintaining a small number of states. In our study, we devised a novel quantitative selection metric that will allow rapid assessment for the optimal number of states (Supplementary Materials and methods) . Overall, we partitioned the thyroid epigenome into 19 states.
In state 15 (labeled as 'repressed'), we find emission of H3K9me3 and H3K27me3 (Fig. 3A) . In the literature, there is limited knowledge of regions containing both H3K9me3 and H3K27me3. Studies have suggested there may be a functional role of H3K9 and H3K27 methylation in coordinating and ensuring progressive lineage restriction during the enactment of the oligodendrocyte 
progenitor differentiation program (Liu et al. 2015) and in a cooperative mechanism in maintaining silencing whereby H3K27me3-bound PRC2 stabilizes H3K9me3-anchored HP1A (Boros et al. 2014) . In another study, it was suggested that the antibody used to enrich H3K27me3 has off-target enrichment for H3K9me3 (Peach et al. 2012) . According to our observations ( Fig. 4A and B) , the stability of this chromatin state across four epigenomes is low and that out of all bins partitioned as state 15, only 3.0% are shared across four epigenomes. Similarly, a bin partitioned as state 15 has a 9% probability of finding the same state in the same bin across three other epigenomes (Fig. 4C) . The lack of conservation of state 15 between epigenomes leads to the question as to whether it has any real biological function or whether it arises as a random chromatin state. In terms of transition probabilities, there exists probability for transitions to occur from heterochromatin state 14 to state 15 and from state 15 to itself, state 14 and quiescent state 19 (Fig. 3A) . These observations suggest that regions containing both H3K9me3 and H3K27me3 may be an intermediate state from heterochromatin to quiescent states.
Overall, 10,460 genes were found to have epigenetically active promoters across all four epigenomes, 1014 genes across three epigenomes, 754 genes across two epigenomes, 947 genes across one epigenome and 6979 genes across no epigenomes (Fig. 5B) . It is striking that in a relatively homogeneous tissue such as the thyroid gland, whose main function is to produce thyroid hormone, approximately half of the known protein coding genes have epigenetically active promoters in all four specimens. With regards to the set of 18 epigenetically active and consistently expressed genes of the thyroid (Table 3) , when we perform a gene set enrichment analysis (Tripathi et al. 2015) , no terms were found enriched. In Table 3 , we present the GO annotation of the individual genes. Interestingly, thyroglobulin (TG), the thyroid prohormone, is excluded from this list of 18 genes that are highly relevant to thyroid function. TG was also not the highest expressed gene in all four specimens (Table 2) and showed high variability, ranging from 8000-20,000 TPM. From the 18 genes, ETFB, NT5C2, SNF8, SORD and TOR1AIP1 appear to be related to metabolism, N4BP2L2 to blood and TPD52 to the immune system (Table 2 ). In the literature, spatacsin, encoded by SPG11, was identified to play critical roles in autophagic lysosome reformation, a pathway that generates new lysosomes (Chang et al. 2014) and TPD52 has been predicted to regulate endolysosomal trafficking in secretory cell types (Byrne et al. 2014) . In the thyroid gland, thyroid hormone is produced (from the breakdown of biomolecules involving lysosomes) and secreted (playing important roles in secretory processes). Thus, it is not unexpected for SPG11 and TPD52 to be of importance to normal thyroid function. With regards to DEPTOR, a mTOR inhibitor, it was suggested as having activity in controlling several molecular pathways, such as apoptosis, cell survival, autophagy and endoplasmic reticulum homeostasis, and it was suggested to play a role as a transcriptional activator (Catena & Fanciulli 2017) . DEPTOR may also play a role in the transcriptional activation of thyroid responsive genes. According to a review by Claudel et al. (2011) , FXR1 belongs to the nuclear receptor superfamily of transcription factors and can bind DNA as a heterodimer with retinoid X receptor (RXR) alpha. Similarly, thyroid hormone receptors binding with T3 can also often heterodimerize with RXR (Panicker 2011) . Thus, we suggest the binding of FXR1 with RXR could influence transcription of thyroidresponsive genes. With regards to PMF1, H2AFY, NSMCE1, SCAF11, TCTN1, TPGS2, VEZT and WBSCR22, we did not find any reports linking these genes with the thyroid, which may suggest potential significance of these genes in the thyroid.
In conclusion, we characterized the normal thyroid epigenome into 19 chromatin states and compared the epigenetic features across four unique thyroid specimens. In general, normal thyroid tissue from nonpathologic human thyroid glands is challenging to obtain for study. However, in spite of the limitation of the specimens being microscopically normal thyroid tissue from thyroid glands with areas of pathology, we defined and found a set of epigenetic features conserved across different individual specimens. We found that epigenetic features characterizing promoters and transcription elongation tend to be more consistent. We also found that every other epigenetic feature tends to be more variable across four individuals, highlighting differences between individuals and the need for biological replicates when deriving reference epigenomes. Furthermore, we found that genes epigenetically active across all epigenomes tend to have higher expression than genes not consistently epigenetically active and we identified a set of 18 genes that are epigenetically active and consistently expressed by the thyroid. Overall, we developed a novel quantitative model selection metric and believe the epigenomes presented in this report represent a valuable resource that will allow for the development of a deeper understanding of the molecular biology that underlies thyroid function and provides important contextual epigenetic information for comparison and integration into future studies.
